ArcaScience is the only AI-native Benefit-Risk Analysis (BRA) platform, built on 23 proprietary AI models, hybridizing LLMs and encoder-based infrastructures—a breakthrough that global pharma giants failed to achieve (Roche’s Voyager, Sanofi’s Darwin, Novartis’ Data42). Nearly a spin-off of INRIA, we deliver instant, AI-driven BRA at scale, where